Sanepar Board Backs Capitalization of Profit Reserves Without Bonus Shares, Pending Shareholder Approval
Bitget2026/11/03 21:04- Sanepar’s board met on October 22, 2026, reviewing financial results and considering capital, governance and policy proposals.
- Directors unanimously authorized submitting a proposal to shareholders to capitalize part of profit reserves without issuing bonus shares.
- The board unanimously agreed to submit proposed corporate bylaws amendments to an extraordinary shareholders’ meeting.
- Directors also unanimously adopted an occupational health and safety policy and revised the sponsorship policy.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
